Pharmacology Cheat Sheet 2026

What Actually Goes Into a Pharmacology Cheat Sheet

Most people think a pharmacology cheat sheet is just a page of drug names and doses. It is not. When I built mine, I spent three weeks pulling from Goodman & Gilman, Katzung, and institutional protocols, then realized I was storing information instead of usable data. The difference matters because you are not going to flip through forty pages during a rapid sequence or a code. You need things you can glance at and act on. Here is how I approach it. I organize everything by clinical scenario rather than by drug class. Yes, that sounds backwards. The traditional way teaches you to memorize beta-blockers, then ACE inhibitors, then diuretics. The real world does not work that way. A patient comes in with hypertensive emergency, and you need to know which drug works in renal failure, which one is contraindicated in aortic stenosis, and which one has an antidote sitting on your crash cart. Grouping by scenario forces you to make those connections while you are building the sheet. I start with a core set of sixty drugs that show up in any acute care environment. These are the ones where dosing errors kill people. Lovenox, heparin, insulin, digoxin, warfarin, amiodarone, lidocaine, nitroglycerin, morphine, fentanyl, midazolam, propofol, vancomycin, piperacillin-tazobactam, cefepime, metronidazole, fluconazole, oseltamivir, acyclovir, sertraline, lisinopril, amlodipine, metoprolol, carvedilol, furosemide, hydrochlorothiazide, spironolactone, atorvastatin, aspirin, clopidogrel, apixaban, rivaroxaban, dabigatran, edoxaban, insulin glargine, insulin lispro, glucagon, dextrose 50%, flumazenil, naloxone, N-acetylcysteine, deferoxamine, digoxin immune fab, sodium bicarbonate, calcium gluconate, adenosine, atropine, epinephrine, vasopressin, norepinephrine, dopamine, dobutamine, milrinone, nitroprusside, labetalol, esmolol, nicardipine, clevidipine, hydralazine, clonidine, allopurinol, colchicine, allopurinol, febuxostat, indomethacin, prednisone, methylprednisolone, dexamethasone, hydrocortisone, hydroxyzine, diphenhydramine, famotidine, omeprazole, pantoprazole, ondansetron, metoclopramide, docusate, senna, polyethylene glycol, lactulose, sorbitol, bisacodyl, magnesium citrate, enemas, suppositories. That list is longer than most people want to look at. I cut it down to what actually moves the needle in your specific setting.

For each drug, I include five fields: indication, starting dose, maximal dose, key monitoring parameter, and the one interaction that gets people fired. Not ten fields. Five. When you are in a real situation, any more detail than that becomes noise. I learned this the hard way after a resident asked me where the reversal agent for a new DOAC was listed. It was on the sheet. He just could not find it because I had buried it under a subsection labeled "Anticoagulant Reversal Agents (Emerging)" instead of putting it next to apixaban and rivaroxaban where it belonged. I restructured the entire document after that. The monitoring parameter field is where most cheat sheets fail. They list lab values that are nice to know but irrelevant in the moment. For vancomycin, the important number is not the trough range from the textbook. It is the creatinine trend over the past forty-eight hours and whether the patient is on a loop diuretic at the same time. Those two pieces of information will save you from a AKI that you could have prevented. For metformin, the critical monitor is not just the A1C. It is the eGFR every six months and the timing of contrast dye administration. I put that in bold on my sheet because I saw a patient nearly die from lactic acidosis after a CT angiogram and nobody checked the metformin. The interaction field is also where people waste space. They list every known interaction from Micromedex. That is not useful. I list one interaction per drug, and it is always the one that is both common and dangerous. Warfarin plus amiodarone increases INR unpredictably. Metronidazole plus warfarin causes bleeding. Clarithromycin plus simvastatin causes rhabdomyolysis. Atorvastatin plus clarithromycin does the same thing. I pick the one that actually happens in my patient population and move on. If someone needs the full interaction profile, they should be using a drug database, not a cheat sheet. That is the whole point of the document.

I format everything in a two-column table with drug name on the left and the five fields on the right. No paragraphs. No explanations. If you need an explanation, you are reading the wrong document. I use color coding for renal dosing adjustments in yellow and hepatic adjustments in orange. It takes about twenty minutes to scan the whole thing and find what you need. That is the target speed. Anything slower means the layout is wrong. There are downsides to this approach. The biggest one is that a single-page reference cannot cover every drug you will ever encounter. If you are working in pediatrics, tox, or psychiatry, your core sixty drugs will look very different from mine. I had a colleague in oncology who spent six months building a sheet that was basically a list of chemotherapy protocols. It was incredibly valuable to her. Useless to me. The format works best when you define your scope early and stick to it. Trying to make one sheet serve every department is a fast track to a document nobody reads. Another limitation is that pharmacology changes. New drugs get approved. Black box warnings change. Dosing recommendations shift based on new trials. My sheet was built on 2024 guidelines. By mid-2025, the IDSA had updated their sepsis guidance and the vancomycin AUC monitoring recommendations had shifted again. I spent a whole Saturday going through every entry and cross-referencing against the latest FDA labels and institutional formulary updates. If you are publishing or sharing a cheat sheet, you need a revision date and you need to treat it as a living document, not something you print once and laminate. I keep a Google Doc version that my team can edit. We review it quarterly. It takes about an hour per review session.

For distribution, I use a PDF that is locked for editing but unlocked for printing. That way nobody accidentally changes a dose and circulates a bad version. I also include a timestamp on the first page showing the last review date. People trust documents more when they can see when they were last updated. It sounds minor. It is not. I have seen colleagues refuse to use a cheat sheet because it had no date, assuming it was outdated. A two-second addition prevents that entire conversation. If you are just starting out, do not build this from scratch. Find an existing template from your institution's pharmacy department or a reputable medical education source. Adapt it. The work is not in the initial layout. The work is in the curation. Deciding what to leave out is harder than deciding what to put in. I deleted more entries than I added during the first month. Each deletion required me to confirm that the drug in question either did not belong in my practice setting or was already covered by a nearby entry. That process took longer than the actual compilation. The final version of my sheet runs about four pages double-sided. It fits on a single card when printed at 50% scale. I keep a laminated copy in my coat pocket and a digital version on my phone. The pocket copy is for quick reference during rounds. The phone version is for when I need to verify a dose or check an interaction detail that does not fit on the card. Two formats serve two different purposes. Using only one means you are always compromising between portability and completeness.

I do not recommend this for board exam studying. The level of detail is too sparse. Board exams test mechanisms, adverse effect profiles, and contraindications across the entire pharmacopeia. A cheat sheet is designed for clinical decision support, not academic assessment. If you are preparing for the NAPLEX or USMLE, you need a different kind of resource. This document assumes you already know the material and need a quick lookup tool. It is not a substitute for studying. It is a supplement for when you are in the environment where the knowledge gets applied. The one thing I wish I had done differently is include a quick-reference dosing table for weight-based medications at the beginning. Pediatric and critical care dosing requires multiplication, and having to flip through sixty entries to find the right calculation is frustrating. I added a small table with common weight-based doses for intubation drugs, vasoactive infusions, and anticoagulants. It took five minutes and saved me probably fifty minutes of flipping back and forth over six months of use. Small additions like that make a disproportionate difference in usability. Download links are tricky because this is a personal document tied to my specific practice setting. I can share the format and methodology. You build your own version for your context. I keep a blank template available for residents who ask. The process of building your own cheat sheet is where the actual learning happens. Copying someone else's document gives you a reference but skips the curation step that makes the document useful. Spend the time doing it yourself. Your future self will thank you during a busy shift when you need the information fast.